206 related articles for article (PubMed ID: 9297448)
1. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2.
Gezginci MH; Martin AR; Franzblau SG
J Med Chem; 2001 May; 44(10):1560-3. PubMed ID: 11334565
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.
Wächter GA; Davis MC; Martin AR; Franzblau SG
J Med Chem; 1998 Jun; 41(13):2436-8. PubMed ID: 9632376
[TBL] [Abstract][Full Text] [Related]
5. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
[TBL] [Abstract][Full Text] [Related]
7. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
8. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
9. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents.
Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents.
Küçükgüzel SG; Rollas S
Farmaco; 2002 Jul; 57(7):583-7. PubMed ID: 12164219
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline derivatives with antitubercular activity.
Kunes J; Bazant J; Pour M; Waisser K; Slosárek M; Janota J
Farmaco; 2000; 55(11-12):725-9. PubMed ID: 11204949
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo]propyl]-2- pyridinecarboxamidrazones.
Mamolo MG; Falagiani V; Vio L; Banfi E
Farmaco; 1999; 54(11-12):761-7. PubMed ID: 10668176
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
16. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
17. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
18. Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.
Mathew B; Srivastava S; Ross LJ; Suling WJ; White EL; Woolhiser LK; Lenaerts AJ; Reynolds RC
Bioorg Med Chem; 2011 Dec; 19(23):7120-8. PubMed ID: 22024272
[TBL] [Abstract][Full Text] [Related]
19. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
20. Aminopyrazinoic acid esters as potential antimycobacterial drugs.
Doležal M; Vobicková J; Servusová B; Paterová P
Ceska Slov Farm; 2013 Apr; 62(2):84-8. PubMed ID: 23822573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
